12/21/2016

When Treatment Stops Working: Blame Resistance

When Treatment Stops Working:  Blame Resistance In the upside down world of prostate cancer, the good guys want to win the war and the bad guys are leading the resistance. Imagine Rick’s Café in Casablanca, except it’s the bad guys, with a nod from Humphrey Bogart, who are the ones.

10/19/2016

Infection and Prostate Cancer

Bacteria, Infection, Inflammation… Cancer? Guess what? Urine’s not sterile! This may be bad news for people like TV survival expert Bear Grylls, who often resorts to drinking his own urine to stay hydrated in the wilderness. But it’s startling and exciting news to scientists, who for years believed that if.

10/19/2016

The Top 7 Things to Know About Prostate Cancer

Educating yourself about prostate cancer is the best way to step up against it. Here are the top 7 things YOU need to know: Prostate cancer is the most common non-skin cancer in America. In the United States, 1 in 8 men will be diagnosed with prostate cancer in his.

10/18/2016

Prostatitis: Misdiagnosed and Misunderstood

Every year, thousands of men are diagnosed with prostatitis. Some of them might even have it. Most of them don’t. Maybe you’re one of those men, and you’ve been taking antibiotics for weeks because your doctor told you that’s what you had. How are your symptoms? Are they any better?.

10/14/2016

The Gleason Score

What is a Gleason Score? After the biopsy of your prostate cancer, your doctor will explain the results to you using something called a Gleason Score. This grading system was devised in the 1960's by a pathologist named Donald Gleason who realized that cancerous cells fall into 5 distinct patterns.

10/13/2016

Interview with an Expert: Active Surveillance

Christopher Barbieri, M.D., Ph.D. Assistant Professor, Urology Assistant Professor, Cell and Developmental Biology Weill Cornell Medicine New York Presbyterian Medical Center “There’s no one way to select candidates for active surveillance,” says  urologist and molecular biologist Chris Barbieri, M.D., Ph.D., who treats men with all kinds of prostate cancer and.

10/13/2016

Active Surveillance:  What You Need to Know

Is active surveillance right for you?  The answer to this question varies, depending on a bunch of factors: your particular form of prostate cancer, your age and general health, and also on the criteria used to select men for active surveillance programs from hospital to hospital. First, what is active.

10/13/2016

A Not-So-Good Practice Proves Harmful in African American Men

It wasn’t that great of an idea to start with: giving hormonal therapy to lower testosterone in men with localized prostate cancer to make them eligible for radiation seed treatment.  The idea is that a short course of hormonal therapy – usually a shot of Lupron or Zoladex – will.

10/12/2016

For Some Advanced Cancers, What Might be Cures

We may have turned the corner.  We’re not there yet, but wow, are we hopeful!  At the Prostate Cancer Foundation, our goal has always been to put ourselves out of business by curing this terrible disease.  Not just by catching it early, or by curing cancer that’s confined to the.

10/12/2016

Genes that Discriminate

“African American men are discriminated against by prostate cancer, and for the first time, we know why.”  This was oncologist Jonathan Simons, M.D., CEO of the Prostate Cancer Foundation, talking to the Congressional Black Caucus at a special symposium on prostate cancer. Simons was telling the lawmakers about the trailblazing.